Literature DB >> 12209603

Increased expression of a COOH-truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells.

Florence Dalenc1, Jerome Drouet, Isabelle Ader, Caroline Delmas, Philippe Rochaix, Gilles Favre, Elizabeth Cohen-Jonathan, Christine Toulas.   

Abstract

We previously demonstrated that transfecting HeLa cells with the 24 kDa basic fibroblast growth factor-2 (FGF-2) isoform dramatically increased cell survival after irradiation. To investigate genes implicated in this radioresistance acquisition, we compared mRNA expression between radioresistant 24 kDa FGF-2-expressing cells (HeLa 3A) and radiosensitive control HeLa PINA cells using the differential display technique. Of the 32 differentially expressed mRNAs, 1 presented a significant homology with a known gene. This 378 bp fragment presented 100% identity with exon 11 and 12 of human nucleophosmin (NPM) but differed by including a part of intron 9 in its 5' end. The differential expression of this fragment was confirmed using an RNase protection assay. We then cloned the entire corresponding mRNA and showed that it contained all the exons of NPM plus intron 9, suggesting that it was a splicing product of the NPM gene. This variant encoded for a 35-amino acid truncated NPM (NPM2). NPM2 expression was increased in HeLa 3A. To investigate NPM2's role in radioresistance acquisition, we transfected HeLa cells with NPM2 cDNA and analyzed survival after irradiation of the clones obtained. After transfection with NPM2, radiosensitive HeLa cells exhibited a dramatic increase in cell survival after irradiation. Taken together, our results demonstrate that expression of a COOH-truncated NPM form resulting from the alternative splicing of NPM mRNA is able to increase cell survival after irradiation and suggests that it might be involved in cellular response to ionizing radiation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209603     DOI: 10.1002/ijc.10558

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.

Authors:  Hideyo Ugai; George C Dobbins; Minghui Wang; Long P Le; David A Matthews; David T Curiel
Journal:  Virology       Date:  2012-06-18       Impact factor: 3.616

2.  Nucleoplasmin regulates chromatin condensation during apoptosis.

Authors:  Zhigang Lu; Chuanmao Zhang; Zhonghe Zhai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

3.  The natural product avrainvillamide binds to the oncoprotein nucleophosmin.

Authors:  Jeremy E Wulff; Romain Siegrist; Andrew G Myers
Journal:  J Am Chem Soc       Date:  2007-10-25       Impact factor: 15.419

4.  Gene mutations and molecularly targeted therapies in acute myeloid leukemia.

Authors:  Eleftheria Hatzimichael; Georgios Georgiou; Leonidas Benetatos; Evangelos Briasoulis
Journal:  Am J Blood Res       Date:  2013-01-17

5.  A HIERARCHICAL BAYESIAN MODEL FOR INFERENCE OF COPY NUMBER VARIANTS AND THEIR ASSOCIATION TO GENE EXPRESSION.

Authors:  Alberto Cassese; Michele Guindani; Mahlet G Tadesse; Francesco Falciani; Marina Vannucci
Journal:  Ann Appl Stat       Date:  2014-03-01       Impact factor: 2.083

6.  Alternative transcript initiation and splicing as a response to DNA damage.

Authors:  Carl N Sprung; Jason Li; Daniel Hovan; Michael J McKay; Helen B Forrester
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

7.  Examination of the FLT3 and NPM1 mutational status in patients with acute myeloid leukemia from southeastern Poland.

Authors:  Dorota Koczkodaj; Szymon Zmorzyński; Małgorzata Michalak-Wojnowska; Ewa Wąsik-Szczepanek; Agata A Filip
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

Review 8.  Nucleophosmin: from structure and function to disease development.

Authors:  Joseph K Box; Nicolas Paquet; Mark N Adams; Didier Boucher; Emma Bolderson; Kenneth J O'Byrne; Derek J Richard
Journal:  BMC Mol Biol       Date:  2016-08-24       Impact factor: 2.946

9.  Analysis of NPM1 splice variants reveals differential expression patterns of prognostic value in acute myeloid leukemia.

Authors:  Malgorzata Zajac; Anna Dolnik; Grazyna Stasiak; Joanna Zaleska; Michal Kielbus; Jakub Czapinski; Matthias Schunn; Stephany C Correa; Eliza Glodkowska-Mrowka; Reddy Chakkarappan Sundaram; Olga Jankowska-Lecka; Richard F Schlenk; Hartmut Döhner; Konstanze Döhner; Andrzej Stepulak; Lars Bullinger; Krzysztof Giannopoulos
Journal:  Oncotarget       Date:  2017-08-03

Review 10.  Function, clinical application, and strategies of Pre-mRNA splicing in cancer.

Authors:  Cuixia Di; Qianjing Zhang; Yuhong Chen; Yupei Wang; Xuetian Zhang; Yang Liu; Chao Sun; Hong Zhang; Jörg D Hoheisel
Journal:  Cell Death Differ       Date:  2018-11-21       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.